Yaiza Pérez-García

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Purpose: Dasatinib is a short-acting dual ABL/SRC family tyrosine kinase inhibitor (TKI), which is frequently used to treat chronic myeloid leukemia. Although very effective, patients taking dasatinib often display severe adverse effects, including pleural effusions and increased risk of bleeding primarily in the gastrointestinal tract. The actual causes of(More)
  • 1